SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.6387
-0.0213 (-3.23%)
At close: Nov 3, 2025, 4:00 PM EST
0.6644
+0.0257 (4.02%)
After-hours: Nov 3, 2025, 7:56 PM EST
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $26.78 million as of November 3, 2025. Its market cap has decreased by -54.07% in one year.
Market Cap
26.78M
Enterprise Value
-14.73M
1-Year Change
-54.07%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $26.78M, a decrease of -64.81%. That is a compound annual growth rate of -8.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 27.70M | -39.65% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
| May 2, 2014 | 76.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 791.67B |
| Johnson & Johnson | 452.47B |
| AbbVie | 380.08B |
| UnitedHealth Group | 299.13B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.23B |